Kromek Group PLC Exercise of Options (2057R)
20 September 2017 - 1:43AM
UK Regulatory
TIDMKMK
RNS Number : 2057R
Kromek Group PLC
19 September 2017
19 September 2017
Kromek Group plc
("Kromek" or the "Company")
Exercise of Options
The Company notifies that, on 15 September 2017, Jerel
Whittingham, a Director of the Company, exercised options over
250,000 ordinary shares of 1 pence each ("Ordinary Shares") in the
capital of the Company, for an exercise price of 1.5 pence per
share. Accordingly, application has been made for 250,000 new
Ordinary Shares to be admitted to trading on AIM. The new Ordinary
Shares will rank pari-passu with existing Ordinary Shares and it is
expected that admission will occur on 25 September 2017.
Following this exercise of options, Mr Whittingham holds 364,890
Ordinary Shares, representing approximately 0.1 per cent of the
Company's enlarged ordinary share capital. Following Admission,
Kromek's issued share capital will comprise 260,395,618 Ordinary
Shares, of which no Ordinary Shares are held in treasury. The total
number of current voting rights in the Company is therefore
260,395,618 Ordinary Shares.
The above figure of 260,395,618 may be used by shareholders as
the denominator for the calculation by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Enquiries
Kromek Group plc
Arnab Basu, CEO +44 (0)1740
Derek Bulmer, CFO 626 060
Cenkos Securities plc
Bobbie Hilliam (NOMAD) +44 (0)20 7397
Julian Morse (Sales) 8900
Luther Pendragon Ltd
Harry Chathli, Claire Norbury, +44 (0)20 7618
Alexis Gore 9100
Template for notification and public disclosure of transactions
by persons discharging managerial responsibilities and persons
closely associated with them
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ------------------------------------------------------------------
a) Name Jerel Whittingham
---- ----------------------------- -----------------------------------
2 Reason for the notification
---- ------------------------------------------------------------------
a) Position/status Director
---- ----------------------------- -----------------------------------
b) Initial notification Initial notification
/Amendment
---- ----------------------------- -----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ------------------------------------------------------------------
a) Name Kromek Group plc
---- ----------------------------- -----------------------------------
b) LEI N/A
---- ----------------------------- -----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ------------------------------------------------------------------
a) Description of Options over ordinary shares
the financial of 1 pence each
instrument, type
of instrument
----
Identification GB00BD7V5D43
code
---- ----------------------------- -----------------------------------
b) Nature of the Exercise of options over
transaction Ordinary Shares of 1 pence
each
---- ----------------------------- -----------------------------------
c) Price(s) and volume(s)
---- ---------------- --------------
Price(s) Volume(s)
---- ---------------- --------------
1.5 pence 250,000
--------------------------------------------------- --------------
d) Aggregated information N/A
----
- Aggregated volume
- Price
e) Date of the transaction 15 September 2017
---- ----------------------------- -----------------------------------
f) Place of the transaction Outside trading venue
---- ----------------------------- -----------------------------------
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County
Durham) and a leading developer of high performance radiation
detection products based on cadmium zinc telluride ("CZT") and
other advanced technologies. Using its core technology platforms,
Kromek designs, develops and produces x-ray and gamma ray imaging
and radiation detection products for the medical, security
screening and nuclear markets.
The Group's products provide high resolution information on
material composition and structure and are used in multiple
applications, ranging from the identification of cancerous tissues
to hazardous materials, such as explosives, and the analysis of
radioactive materials.
The Group's business model provides a vertically integrated
technology offering to customers, from radiation detector materials
to finished products or detectors, including software, electronics
and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and
Pennsylvania), and is selling internationally through a combination
of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees
across its global operations. Further information on Kromek Group
is available at www.kromek.com and
https://twitter.com/kromekgroup.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEEKLFFDKFZBBL
(END) Dow Jones Newswires
September 19, 2017 11:43 ET (15:43 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024